REVIEW PAPER
Swept-source optical coherence tomography angiography in diagnosing radiation retinopathy after choroidal melanoma plaque brachytherapy
1
Ophthalmic Clinic, Voivodeship Hospital, Kielce, Poland
2
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
3
Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland
Submission date: 2023-12-04
Acceptance date: 2024-08-21
Publication date: 2024-12-02
Corresponding author
Michał Brzdęk
Michał Brzdęk Collegium Medicum Department of Infectious Diseases Jan Kochanowski University Kielce, Poland
Michał Brzdęk Collegium Medicum Department of Infectious Diseases Jan Kochanowski University Kielce, Poland
Medical Studies 2025;41(1):38-44
KEYWORDS
TOPICS
ABSTRACT
Radiation retinopathy is ischaemic damage to the retina and choroid following brachytherapy of intraocular tumours and head and neck tumours. It can lead to vision loss in patients treated with radiation due to choroidal melanoma. Patients following this type of treatment should be systematically monitored for tumour recurrence, metastases, and ischaemic radiation retinopathy. Follow-up should include a fundus examination and additional tests such as optical coherence tomography angiography (OCTA), fluorescein angiography (FA), and B-scan ultrasonography. OCTA proves to be a valuable diagnostic tool for early detection and treatment of radiation retinopathy, offering detailed vascular maps and effectively identifying radiation retinopathy features, complementing traditional methods like fluorescein angiography.
REFERENCES (47)
1.
Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, Stern MH, Carvajal RD, Belfort RN, Jia R, Shields JA, Damato BE. Uveal melanoma. Nat Rev Dis Primers. 2020; 6: 24.
2.
Piperno-Neumann S, Piulats J, Goebeler M, Galloway I, Lugowska I, Becker J, Vihinen P, Van Calster J, Hadjistilianou T, Proença R, Caminal JM, Rogasik M, Blay JY, Kapiteijn E. Uveal melanoma: a European network to face the many challenges of a rare cancer. Cancers (Basel). 2019; 11: 817.
3.
Finger P, Garg G, Kivelä T. Patients presenting with stage IV uveal melanoma: lessons learned. Indian J Ophthalmol. 2022; 70: 271.
4.
Kamrava M, Lamb J, McCannel TA. Ocular complications of radiotherapy. In: Clinical Ophthalmic Oncology. Basic principles and diagnostic techniques. Second edition, Springer Berlin, Heidelberg 2014; 99-111.
5.
Kaliki S, Shields C, Shields J. Uveal melanoma: estimating prognosis. Indian J Ophthalmol. 2015; 63: 93-102.
6.
Naseripoor M, Azimi F, Mirshahi R, Khakpoor G, Poorhosseingholi A, Chaibakhsh S. Global incidence and trend of uveal melanoma from 1943-2015: a meta-analysis. Asian Pac J Cancer Prev. 2022; 23: 1791-1801.
7.
Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye. 2017; 31: 241-257.
8.
Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, Esmaeli B, Grimm EA, Wargo JA, Woodman SE, Patel SP. Uveal melanoma: from diagnosis to treatment and the science in between. Cancer. 2016; 122: 2299-2312.
9.
Foti PV, Travali M, Farina R, Palmucci S, Spatola C, Raf- faele L, Salamone V, Caltabiano R, Broggi G, Puzzo L, Russo A, Reibaldi M, Longo A, Vigneri P, Avitabile T, Ettor- re GC, Basile A. Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging – Part I: MR imaging with pathologic correlation and technical considerations. Insights Imaging. 2021; 12: 66.
10.
Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012; 9: 193-199.
11.
Reichstein DA, Brock AL. Radiation therapy for uveal melanoma: a review of treatment methods available in 2021. Curr Opin Ophthalmol. 2021; 32: 183-190.
12.
Rusňák Š, Hecová L, Kasl Z, Sobotová M, Hauer L. Therapy of uveal melanoma. A review. Cesk Slov Oftalmol. 2021; 77: 3-15.
13.
Sahoo NK, Ranjan R, Tyagi M, Agrawal H, Reddy S. Radiation retinopathy: detection and management strategies. Clin Ophthalmol. 2021; 15: 3797-3809.
14.
Abri Aghdam K, Soltan Sanjari M, Naseripour M, Ma- nafi N, Sedaghat A, Bakhti S. The impacts of episcleral plaque brachytherapy on ocular motility. J Binocul Vis Ocul Motil. 2021; 71: 55-61.
15.
Akbaba S, Foerster R, Nicolay NH, Arians N, Bostel T, De- bus J, Hauswald H. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma. Radiat Oncol. 2018; 13: 140.
16.
Rose K, Krema H, Durairaj P, Dangboon W, Chavez Y, Kulasekara SI, Hudson C. Retinal perfusion changes in radiation retinopathy. Acta Ophthalmol. 2018; 96: e727-e731.
17.
Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma I. Visual acuity after 3 years COMS report no. 16. Ophthalmology. 2001; 108: 348-366.
18.
Krema H, Xu W, Payne D, Vasquez LM, Pavlin CJ, Simpson R. Factors predictive of radiation retinopathy post 125Iodine brachytherapy for uveal melanoma. Can J Ophthalmol. 2011; 46: 158-163.
19.
Shields JA, Shields CL. Current management of posterior uveal melanoma. Mayo Clin Proc. 1993; 68: 1196-1200.
20.
Stallard HB. Radiant energy as (a) a pathogenic (b) a therapeutic agent in ophthalmic disorders. Br J Ophthalmol Monograph Suppl. 1933; 6: 1-126.
21.
Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adijacents tissue. Eye. 2013; 27: 163-171.
22.
Guyer DR, Mukai S, Egan KM, Seddon JM, Walsh SM, Gragoudas ES. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology. 1992; 99: 1278-1285.
23.
Shields JA, Shields CL. Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture. Ophthalmology. 2015; 122: 414-428.
24.
Płatkowska B, Kal M, Biskup M. Optical coherence tomography angiography – use in ophthalmological practice. Med Stud. 2020; 36: 195-205.
26.
Tseng VL, Coleman AL, Zhang ZF, McCannel TA. Complications from plaque versus proton beam therapy for choroidal melanoma: a qualitative systematic review. J Cancer Ther. 2016; 7: 169-185.
27.
Seregard S, Pelayes DE, Singh AD. Radiation therapy: posterior segment complications. Dev Ophthalmol. 2013; 52: 114-123.
28.
Atebara NH, Drouilhet JH, Brown GC. Duane’s ophthalmology on CD-ROM. Wilkins, Philadelphia, PA 2006.
29.
Giuliari GP, Sadaka A, Hinkle DM, Simpson ER. Current treatments for radiation retinopathy. Acta Oncol. 2011; 50: 6-13.
30.
Reichstein D. Current treatments and preventive strategies for radiation retinopathy. Curr Opin Ophthalmol. 2015; 26: 157-166.
31.
Fujimoto JG, Brezinski ME, Tearney GJ, Boppart SA, Bouma B, Hee MR, Southern JF, Swanson EA. Optical biopsy and imaging using optical coherence tomography. Nat Med. 1995; 1: 970-972.
32.
Kal M, Winiarczyk M, Zarębska-Michaluk D, Odrobi- na D, Cieśla E, Płatkowska-Adamska B, Biskup M, Pab- jan P, Głuszek S, Mackiewicz J. Long-term effect of SARS-CoV-2 infection on the retinal and choroidal microvasculature. J Clin Med. 2023; 12: 2528.
33.
Theodossiasis G. Optyczna koherentna tomografia choroby siatkówki – jaskra. Partner, Wrocław 2010.
34.
Huber R, Adler DC, Fujimoto JG. Buffered Fourier domain mode locking: Unidirectional swept laser sources for optical coherence tomography imaging at 370,000 lines/s. Opt Lett. 2006; 31: 2975-2977.
35.
Michalewska Z, Michalewski J, Nawrocki J. Swept-source OCT. Retina Today. 2013: 50-56.
36.
Waldstein SM, Faatz H, Szimacsek M, Glodan AM, Podkowinski D, Montuoro A, Simader C, Gerendas BS, Schmidt-Erfurth U. Comparison of penetration depth in choroidal imaging using swept source vs spectral domain optical coherence tomography. Eye. 2015; 29: 409-415.
37.
Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, Kraus MF, Subhash H, Fujimoto JG, Hornegger J, Huang D. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express. 2012; 20: 4710-4725.
38.
Spaide RF, Fujimoto JG, Waheed NK. Image artifacts in optical coherence tomography angiography. Retina. 2015; 35: 2163-2180.
39.
Sawada O, Ichiyama Y, Obata S, Ito Y, Kakinoki M, Sawada T, Saishin Y, Ohji M. Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy. Arbeitsphysiologie. 2018; 256: 1275-1280.
40.
Cennamo G, Montorio D, Bernardo R, Farella A, Liuzzi R, Breve MA, Reibaldi M, Cennamo G. Retinal vascular changes in Radiation Maculopathy after intravitreal Ranibizumab by optical coherence tomography angiography. J Clin Med. 2020; 9: 1618.
41.
Sellam A, Coscas F, Lumbroso-Le Rouic L, Dendale R, Lupidi M, Coscas G, Desjardins L, Cassoux N. Optical coherence tomography angiography of macular features after proton beam radiotherapy for small choroidal melanoma. Am J Ophthalmol. 2017; 181: 12-19.
42.
Say EAT, Samara WA, Khoo CTL, Magrath GN, Sharma P, Ferenczy S, Shields CL Parafoveal capillary density after plaque radiotherapy for choroidal melanoma. Retina. 2016; 36: 1670-1678.
43.
Rose K, Krema H, Durairaj P, Dangboon W, Hudson C. Retinal perfusion changes in radiation retinopathy. Acta Ophthalmol. 2018; 96: e727-e731.
44.
Archer D, Amoaku W, Gardiner T. Radiation retinopathy – clinical, histopathological, ultrastructural and experimental correlations. Eye. 1991; 5: 239-251.
45.
Irvine AR, Alvarado JA, Wara WM, Morris BW, Wood IS. Radiation retinopathy: an experimental model for the ischemic-proliferative retinopathies. Trans Am Ophthalmol Soc. 1981; 79: 103-122.
46.
Rilvén S, Torp TL, Grauslund J. Retinal oximetry in patients with ischaemic retinal diseases. Acta Ophthalmol. 2017; 95: 119-127.
47.
Higginson DS, Sahgal A, Lawrence MV, Moyer S, Stefanescu M, Willson AK, Qaqish B, Zanation A, Marks LB, Garg S, Chera BS. External beam radiotherapy for head and neck cancers is associated with increased variability in retinal vascular oxygenation. PLoS One. 2013; 8: e69657.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
